Teva Pharmaceutical Industries Limited (TLV:TEVA)

TLV:TEVA Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 15, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	114,600	91,081	42,146	35,617	27,480	34,000
Market Cap Growth	25.82%	116.11%	18.33%	29.61%	-19.18%	-8.03%
Enterprise Value	161,437	150,359	109,242	106,456	99,359	115,222
Last Close Price	101.50	81.01	38.15	32.99	26.95	30.55
PE Ratio	48.54	-	-	-	21.19	-
PS Ratio	2.06	1.51	0.74	0.68	0.56	0.64
PB Ratio	4.77	4.37	1.44	1.18	0.79	0.96
P/FCF Ratio	59.88	33.39	13.90	9.72	37.44	16.58
P/OCF Ratio	32.47	20.05	8.56	6.37	11.07	8.70
EV/Sales Ratio	3.06	2.50	1.91	2.03	2.01	2.15
EV/EBITDA Ratio	10.83	9.32	7.00	7.63	7.25	7.77
EV/EBIT Ratio	14.31	12.24	9.54	11.37	10.38	11.73
EV/FCF Ratio	84.35	55.12	36.03	29.06	135.36	56.18
Debt / Equity Ratio	2.36	3.18	2.50	2.52	2.10	2.40
Debt / EBITDA Ratio	3.61	3.98	4.53	5.26	5.19	5.57
Debt / FCF Ratio	29.57	24.28	24.08	20.80	99.97	41.59
Asset Turnover	0.41	0.40	0.36	0.33	0.32	0.31
Inventory Turnover	2.30	2.41	2.09	2.08	2.02	2.02
Quick Ratio	0.52	0.50	0.54	0.57	0.61	0.51
Current Ratio	1.11	0.98	1.02	1.05	1.14	0.99
Return on Equity (ROE)	9.71%	-28.30%	-7.36%	-25.19%	4.09%	-31.38%
Return on Assets (ROA)	5.49%	5.09%	4.54%	3.63%	3.91%	3.53%
Return on Capital (ROIC)	8.95%	8.06%	6.78%	5.11%	5.31%	4.77%
Return on Capital Employed (ROCE)	12.60%	12.70%	10.20%	8.20%	8.40%	8.20%
Earnings Yield	2.06%	-6.55%	-4.78%	-24.15%	4.72%	-37.73%
FCF Yield	1.67%	3.00%	7.20%	10.29%	2.67%	6.03%
Buyback Yield / Dilution	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%
Total Shareholder Return	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.